SEC Form 4 · accession 0000899243-15-001566
CHIASMA, INC · CHMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jul 21, 2015
Accepted (ET)
Jul 23, 2015 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339469
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 21, 2015 | C | 12,337 | — | A | 12,337 | D | |
| Common StockF1 | Jul 21, 2015 | C | 760,656 | — | A | 772,993 | D | |
| Common StockF1 | Jul 21, 2015 | C | 514,674 | — | A | 1,287,667 | D | |
| Common StockF1 | Jul 21, 2015 | C | 328,515 | — | A | 1,616,182 | D | |
| Common StockF1,F2,F3 | Jul 21, 2015 | C | 273,762 | — | A | 273,762 | I | Directly owned by Ruth Wertheimer |
| Common StockF2,F3 | Jul 21, 2015 | P | 93,750 | $16.00 | A | 93,750 | I | Directly owned by Ruth Wertheimer |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B1' Convertible Preferred StockF1,F5 | — | Jul 21, 2015 | C | 112,665 | A | — | — | Common Stock | 12,337 | 0 | D |
| Series C' Convertible Preferred StockF1,F5 | — | Jul 21, 2015 | C | 6,946,314 | A | — | — | Common Stock | 760,656 | 0 | D |
| Series D' Convertible Preferred StockF1,F5 | — | Jul 21, 2015 | C | 4,700,000 | A | — | — | Common Stock | 514,674 | 0 | D |
| Series E Convertible Preferred StockF1,F5 | — | Jul 21, 2015 | C | 3,000,000 | A | — | — | Common Stock | 328,515 | 0 | D |
| Series E Convertible Preferred StockF1,F2,F3,F5 | — | Jul 21, 2015 | C | 2,500,000 | A | — | — | Common Stock | 273,762 | 0 | I |
Explanation of responses
- F1Each outstanding share of the Issuer's Series B-1' Preferred Stock, Series C' Preferred Stock, Series D' Preferred Stock and Series E Preferred Stock converted into 0.109505 of a share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The converted shares had no expiration date.
- F2Besides the shares of Common Stock and warrants to purchase shares of Common Stock held directly by Ruth Wertheimer, she also owns (i) an indirect, 80.5% limited partnership interest in 7 Med Health Ventures LP, as well as (ii) 100% of the outstanding equity interests of the general partner of 7 Med Health Ventures LP. She may therefore be deemed to have an indirect pecuniary interest in the shares of Common Stock and Warrants to purchase Common Stock of the Issuer held by 7 Med Health Ventures LP.
- F3Ruth Wertheimer disclaims beneficial ownership of securities held by 7 Med Health Ventures LP except to the extent of her pecuniary interest therein.
- F4The Reporting Person purchased the shares of Common Stock reported in this row in the Issuer's registered initial public offering in the United States.
- F5Each share of the Issuer's Series B1' preferred stock, Series C preferred stock, Series D' preferred stock and Series E preferred stock was automatically converted on a 9.132-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series B1', Series C' and Series D' and Series E preferred stock had no expiration date.